ISN 9.09% 6.0¢ isonea limited

selling exhausted, page-27

  1. 8,443 Posts.
    lightbulb Created with Sketch. 175
    I know the US has more people which will equal more people with asthma, but the AUS market would be more then big enough to start trying to sell the wheezometer here in AUS.

    Why go to the trouble of going through the FDA to be able to sell the device without a prescription when they can sell it here in AUS without one?

    Seems a bit strange to me that their focusing all their time and energy on the US when they have a perfectly good market here in AUS to try and market it to......

    From what I gather no FDA approval is needed to sell it here in AUS as u can buy it over the Internet in AUS without any trouble.

    Something to think about?? They could have had revenue and sales already if they targeted AUS first......

    Seems odd to me.
 
watchlist Created with Sketch. Add ISN (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.